Iberogast drops for oral administration 50 ml

Release form, composition and packaging

Drops for oral administration from clear to slightly turbid liquid of dark brown color

during storage, the formation of a slight sediment is allowed.

100 ml

liquid extract of whole fresh plant Iberis amara L., Cruciferae 1: 1.5-2.5 * 15 ml

liquid extract of dry roots of Angelica officinalis (Angelica archangelica L., Umbelliferae) 1: 2.5-3.5 ** 10 ml

liquid extract of dried chamomile flowers (Martricaria chamomilla L., Compositae) 1: 2.0-4.0 ** 20 ml

liquid extract of dry fruits of caraway seeds (Carum carvi L., Umbelliferae) 1: 2.5-3.5 ** 10 ml

liquid extract of dry fruits of milk thistle (Silybum marinum L., Gaertn., Compositae) 1: 2.5-3.5 ** 10 ml

liquid extract of dry leaves of lemon balm (Melissa officinalis L., Labiatae) 1: 2.5-3.5 ** 10 ml

liquid extract of dry leaves of peppermint (Mentha piperita L., Labiatae) 1: 2.5-3.5 ** 5 ml

liquid extract of dry herb celandine may (Chelidonium majus L., Papaveracea) 1: 2.5-3.5 ** 10 ml

liquid extract of dry roots of licorice naked (Glycyrrhiza glabra L., Leguminosae) 1: 2.5-3.5 ** 10 ml

* Extractant: ethanol 50%.

** Extractant: ethanol 30%.

ethanol - about 31% (v / v).

50 ml - dark glass bottles with a dropper (1) - cardboard packs.

100 ml - dark glass bottles with a dropper (1) - cardboard packs.

pharmachologic effect

The drug has a pronounced anti-inflammatory effect, and also normalizes the tone of smooth muscles of the gastrointestinal tract: it helps to eliminate spasm without affecting normal peristalsis, and with a reduced tone and motility it has a tonic, prokinetic effect.

In an in vitro experiment, it inhibits the growth of 6 subspecies of Helicobacter pylori.

Iberogast reduces the intensity of ulceration of the gastric mucosa, the secretion of hydrochloric acid, reduces the concentration of leukotrienes, enhances the production of mucins, increases the concentration of mucoprotective prostaglandin E2 in the gastric mucosa.

Pharmacokinetics

There are no data on the pharmacokinetics of the drug.

Indications for use

- for the treatment of functional disorders of the gastrointestinal tract (including irritable bowel syndrome), manifested by severity in the epigastric region, stomach or intestinal cramps, belching, nausea, flatulence, constipation, diarrhea, or their alternation

- as part of the complex therapy of gastritis, gastric ulcer and duodenal ulcer.

Contraindications for use

- calculous cholecystitis

- children and adolescents under 12 years of age (due to insufficient clinical data)

- hypersensitivity to drug components.

Care should be taken to prescribe the drug for liver diseases, alcoholism, traumatic brain injury, brain diseases - due to the ethanol content in the drug.

Dosage regimen

The drug is taken orally, 20 drops 3 times / day, before or during meals, with a little water.

The duration of therapy is 4 weeks.

An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.

Overdose

To date, no cases of drug overdose have been reported.

Side effect

From the digestive system: nausea, vomiting, diarrhea.

Allergic reactions: skin manifestations, shortness of breath.

If adverse reactions occur, it is necessary to cancel the drug and consult a doctor.

Drug interactions

Interaction with other drugs is currently unknown.

Consideration should be given to the possibility of interaction with drugs, the metabolism of which is carried out with the participation of the cytochrome P450 system (licorice roots, milk thistle fruits, chamomile flowers can have an inhibitory effect on a number of cytochrome P450 isoenzymes).

Moreover, these effects carry a dose

Name ENG

IBEROGAST

Clinical and pharmacological group

Phytopreparation used for gastrointestinal diseases

ATX code

Other drugs used for bowel dysfunction

Dosage

etc.

x 50ml

Structure

Indications

The drug is used to treat functional disorders of the gastrointestinal tract (including irritable bowel syndrome), manifested by severity in the epigastric region, stomach or intestinal cramps, belching, nausea, flatulence, constipation, diarrhea or their alternation, as well as as part of complex therapy gastritis, gastric ulcer and duodenal ulcer.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

after opening - 4 weeks

INN / Active ingredient

Peppermint leaves dry extract liquid + licorice naked roots dry extract liquid + lemon balm leaves dry extract liquid + angelica root dry extract liquid + celandine may herb dry liquid extract + milk thistle fruit dry extract liquid + caraway common fruit dry extract liquid + ibberia bitter whole fresh plant liquid extract + chamomile flower dry extract liquid

Contraindications

Hypersensitivity to drug components, calculous cholecystitis.

Children's age (up to 18 years old) - (due to insufficient clinical data).

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the medicinal product

Gastrointestinal tract

Release form

Drops

Manufacturer country

Germany

Package quantity, pcs

one

Scope of application

Gastroenterology

Minimum age from

18 years

Contraindications dietary supplements

Dietary supplement.

NOT A DRUG

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

50 ml

Brand name

Iberogast

The amount of the dosage form in the primary package

50 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal remedy

Dosage form

Drops for oral administration

Expiration date in days

730

The target audience

Adult

Package weight, g

60

Mode of application

:

Take before meals or with meals, with a little water, 20 drops, 3 times a day.

The duration of therapy is 4 weeks.

An increase in the duration of the course and repeated courses of treatment are possible on the recommendation of a doctor.

Information on technical characteristics, delivery set, country of manufacture